Manchester Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Manchester Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-34	Closed	-$2K	–	957
2014 Q4	$2K	Hold	34	–	–	﹤0.01%	1088
2014 Q3	$3K	Hold	34	–	–	﹤0.01%	1047
2014 Q2	$4K	Buy	+34	New	+$2.36K	﹤0.01%	1032

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manchester Capital Management's GWPH Position: Q1 2015 in Review

Manchester Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2015, closing a stake of 34 shares — an estimated $2K sold.

Manchester Capital Management first reported a position in GWPH in Q2 2014 and held it in 3 quarters. The position peaked at $4K in Q2 2014. 92 funds tracked by Wall St. Rank hold GWPH as of Q1 2015.

Manchester Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2015 after selling out during the quarter.
Manchester Capital Management sold 34 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2015, an estimated $2K.
Manchester Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 3 quarters.
Manchester Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4K in Q2 2014.
92 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2015.

Based on Manchester Capital Management's 13F filing for Q1 2015, filed 7 May 2015.